Online Presentations Address Outcomes Reporting
for Allogeneic Stem Cell Transplants

A new federal law requires the measurement and reporting of outcomes of all related and unrelated allogeneic blood transplants.  The transplant center-specific data will be recorded in a public registry.

Two sessions at the BMT Tandem Meetings on Feb. 8 and 11 in Keystone, Colo., addressed the details and ramifications of the new law.  If you did not have the opportunity to attend the meetings, or you would like to review particular sessions, the presentations can be viewed online or downloaded to your computer for later viewing.
 

Click here to access the programs that are listed below.  There is no charge for online viewing or download.

Measuring and Reporting Treatment Outcomes:  Impact    of the C.W. Bill Young Cell Transplantation Program    (Concurrent Scientific Session, Thursday, Feb. 8, 2007)     ■  Overview of the C.W. Bill Young Cell Transplantation         Program               Dennis L. Confer, MD     ■  Requirements for the Stem Cell Therapeutic Outcomes         Database               J. Douglas Rizzo, MD, MS     ■  The Relationship between SCTOD and Other CIBMTR         Programs               Mary M. Horowitz, MD, MS      Quality Outcomes Reporting: Getting Ready for HRSA’s    New Requirements     (BMT Medical Directors Conference, Sunday, Feb. 11, 2007)      ■  ASBMT, the C.W. Bill Young Transplantation Act, and         Quality Outcomes Reporting:  An Update               Roy B. Jones, MD, PhD     ■  Solid Organ Transplantation and Outcomes Reporting:          An Analysis               Ian Jamieson, MBA, MHA     ■  AGNIS: A Growable Network for Information Sharing               Dennis L. Confer, MD     ■  CIBMTR and the Stem Cell Transplantation Outcomes         Database (SCTOD)               J. Douglas Rizzo, MD, MS     ■  How Can Centers Respond?               Patrick Stiff, MD, and Roy B. Jones, MD, PhD